 evidence

A (High)

We recommend using Food and Drug Administration
(FDA)-approved branch endograft devices in anatomically suitable patients to maintain perfusion to at least
one internal iliac artery.

We recommend staging bilateral internal iliac artery occlusion by at least 1 to 2 weeks if required for EVAR.
Level of recommendation

1 (Strong)

Quality of evidence

A (High)

We suggest renal artery or superior mesenteric artery
(SMA) angioplasty